\-\ Texto\\:\\ \ \(0\)\
\-\ generally\\ poor\\ prognosis\\.\\ 5\\ year\\ mean\\ survival\\ rate\\ of\\ 20\\%\\.\\ mean\\ survival\\ of\\ 3\\-4\\ years\\ following\\ onset\\ of\\ symptoms\\.\\ treatment\\ is\\ largely\\ ineffective\\.\ \(0\)\
\-\ ct\\ scan\\:\\ severe\\ emphysematous\\ and\\ bullous\\ changes\\ of\\ the\\ upper\\ lobes\\.\\ \\ peripheral\\ honeycombing\\ and\\ marked\\ interstitial\\ thickening\\ is\\ noted\\ at\\ more\\ inferior\\ levels\\.\\ \\ \\(unfortunately\\,\\ axial\\ images\\ at\\ the\\ lung\\ bases\\ demonstrating\\ the\\ marked\\ apicobasal\\ gradient\\ of\\ interstitial\\ and\\ subpleural\\ findings\\ was\\ not\\ submitted\\ with\\ this\\ case\\)\\.\ \(0\)\
\-\ idiopathic\\ pulmonary\\ fibrosis\\ \\(usual\\ interstitial\\ pneumonia\\)\ \(0\)\
\-\ idiopathic\\ pulmonary\\ fibrosis\\ \\(usual\\ interstitial\\ pneumonia\\)\ \(0\)\
\-\ nonspecific\\ interstitial\\ pneumonia\ \(0\)\
\-\ other\\ interstitial\\ pneumonias\ \(0\)\
\-\ collagen\\ vascular\\ dz\ \(0\)\
\-\ asbestosis\ \(10\)\
\-\ radiation\\/drug\\ toxicity\ \(0\)\
\-\ 60\\ pack\\ year\\ history\\ of\\ tobacco\\ use\ \(1\)\
\-\ this\\ patient\\ had\\ a\\ biopsy\\ showing\\ the\\ characteristic\\ usual\\ interstitial\\ pneumonia\\ \\(normal\\ lung\\ with\\ interstitial\\ inflammation\\,\\ fibroblastic\\ proliferation\\,\\ interstitial\\ fibrosis\\,\\ honeycombing\\)\\ as\\ well\\ as\\ pfts\\ showing\\ restrictive\\ lung\\ disease\\ with\\ impaired\\ gas\\ exchange\\ to\\ make\\ the\\ diagnosis\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ interstitial\\:\\ 0\\.6068667362954722\ \(0\)\
\-\ pneumonia\\:\\ 0\\.2348351211195016\ \(0\)\
\-\ usual\\:\\ 0\\.23172781467186743\ \(0\)\
\-\ honeycombing\\:\\ 0\\.18715542652596603\ \(0\)\
\-\ fibrosis\\:\\ 0\\.18693276382370766\ \(0\)\
\-\ mean\\:\\ 0\\.16401586347376348\ \(0\)\
\-\ survival\\:\\ 0\\.14518365153045704\ \(0\)\
\-\ lung\\:\\ 0\\.13573994070442588\ \(0\)\
\-\ showing\\:\\ 0\\.12844504565924492\ \(0\)\
\-\ idiopathic\\:\\ 0\\.1258350161757385\ \(0\)\
\-\ apicobasal\\:\\ 0\\.11895095143099192\ \(0\)\
\-\ marked\\:\\ 0\\.11251343478573593\ \(0\)\
\-\ exchange\\:\\ 0\\.10462585462823872\ \(0\)\
\-\ bullous\\:\\ 0\\.10261584305863139\ \(0\)\
\-\ pneumonias\\:\\ 0\\.10261584305863139\ \(0\)\
\-\ fibroblastic\\:\\ 0\\.10261584305863139\ \(0\)\
\-\ pfts\\:\\ 0\\.09933888762113385\ \(0\)\
\-\ ineffective\\:\\ 0\\.09796506393323744\ \(0\)\
\-\ restrictive\\:\\ 0\\.09672228923822651\ \(0\)\
\-\ dz\\:\\ 0\\.09267809692613257\ \(0\)\
\-\ subpleural\\:\\ 0\\.09183656204404685\ \(0\)\
\-\ asbestosis\\:\\ 0\\.0910460615325301\ \(0\)\
\-\ pulmonary\\:\\ 0\\.09067694618216014\ \(0\)\
\-\ toxicity\\:\\ 0\\.0903007578254855\ \(0\)\
\-\ of\\:\\ 0\\.087335856839942\ \(0\)\
\-\ largely\\:\\ 0\\.08501379081838065\ \(0\)\
\-\ impaired\\:\\ 0\\.08453958346733466\ \(0\)\
\-\ emphysematous\\:\\ 0\\.08363996713048422\ \(0\)\
\-\ proliferation\\:\\ 0\\.0798888043419407\ \(0\)\
\-\ tobacco\\:\\ 0\\.07894579606809073\ \(0\)\
\-\ submitted\\:\\ 0\\.07864602964692978\ \(0\)\
\-\ gradient\\:\\ 0\\.07806641133349167\ \(0\)\
\-\ pack\\:\\ 0\\.07724260489062247\ \(0\)\
\-\ unfortunately\\:\\ 0\\.07672096472977688\ \(0\)\
\-\ bases\\:\\ 0\\.07646776716181194\ \(0\)\
\-\ collagen\\:\\ 0\\.0755014536716863\ \(0\)\
\-\ the\\:\\ 0\\.074208236156537\ \(0\)\
\-\ make\\:\\ 0\\.07222449823418878\ \(0\)\
\-\ nonspecific\\:\\ 0\\.06990766627244235\ \(0\)\
\-\ prognosis\\:\\ 0\\.06545549724981271\ \(0\)\
\-\ gas\\:\\ 0\\.06513615234894478\ \(0\)\
\-\ generally\\:\\ 0\\.06300651365554247\ \(0\)\
\-\ poor\\:\\ 0\\.06274129912204454\ \(0\)\
\-\ lobes\\:\\ 0\\.06205935208812812\ \(0\)\
\-\ demonstrating\\:\\ 0\\.06133251759810211\ \(0\)\
\-\ characteristic\\:\\ 0\\.06013265878945139\ \(0\)\
\-\ inflammation\\:\\ 0\\.059779269544116304\ \(0\)\
\-\ as\\:\\ 0\\.059762743728109205\ \(0\)\
\-\ levels\\:\\ 0\\.05896827670552288\ \(0\)\
\-\ use\\:\\ 0\\.05691154611411543\ \(0\)\
\-\ rate\\:\\ 0\\.05636359721287421\ \(0\)\
\-\ at\\:\\ 0\\.056189073216472304\ \(0\)\
\-\ 60\\:\\ 0\\.05563320745579713\ \(0\)\
\-\ peripheral\\:\\ 0\\.05318839464683864\ \(0\)\
\-\ biopsy\\:\\ 0\\.05213822707328472\ \(0\)\
\-\ this\\:\\ 0\\.05111710435257255\ \(0\)\
\-\ thickening\\:\\ 0\\.05060242285472337\ \(0\)\
\-\ inferior\\:\\ 0\\.05060242285472337\ \(0\)\
\-\ vascular\\:\\ 0\\.04910500331220386\ \(0\)\
\-\ 20\\:\\ 0\\.04798582447181601\ \(0\)\
\-\ onset\\:\\ 0\\.047761968930313564\ \(0\)\
\-\ severe\\:\\ 0\\.04708620813496556\ \(0\)\
\-\ and\\:\\ 0\\.0461095905685256\ \(0\)\
\-\ year\\:\\ 0\\.045845342097424434\ \(0\)\
\-\ years\\:\\ 0\\.04559438124320093\ \(0\)\
\-\ changes\\:\\ 0\\.04495260071073515\ \(0\)\
\-\ following\\:\\ 0\\.04462135685996004\ \(0\)\
\-\ scan\\:\\ 0\\.04412925072088037\ \(0\)\
\-\ with\\:\\ 0\\.04369401999679643\ \(0\)\
\-\ axial\\:\\ 0\\.04296497415097765\ \(0\)\
\-\ more\\:\\ 0\\.04084296652960623\ \(0\)\
\-\ is\\:\\ 0\\.04073932672214719\ \(0\)\
\-\ symptoms\\:\\ 0\\.04069691225170816\ \(0\)\
\-\ upper\\:\\ 0\\.039747900632892505\ \(0\)\
\-\ noted\\:\\ 0\\.039436544662143844\ \(0\)\
\-\ other\\:\\ 0\\.03862709798582677\ \(0\)\
\-\ diagnosis\\:\\ 0\\.0385584339775761\ \(0\)\
\-\ case\\:\\ 0\\.03736806095403563\ \(0\)\
\-\ had\\:\\ 0\\.03705920556149677\ \(0\)\
\-\ findings\\:\\ 0\\.03670986486481917\ \(0\)\
\-\ well\\:\\ 0\\.03601550748201508\ \(0\)\
\-\ treatment\\:\\ 0\\.03543147995640984\ \(0\)\
\-\ images\\:\\ 0\\.03440603137610739\ \(0\)\
\-\ disease\\:\\ 0\\.03122238055881094\ \(0\)\
\-\ normal\\:\\ 0\\.03036914602135519\ \(0\)\
\-\ not\\:\\ 0\\.029363735819042124\ \(0\)\
\-\ history\\:\\ 0\\.028417737988754653\ \(0\)\
\-\ ct\\:\\ 0\\.02831743545543279\ \(0\)\
\-\ was\\:\\ 0\\.025922414582395952\ \(0\)\
\-\ patient\\:\\ 0\\.02419231166105783\ \(0\)\
\-\ to\\:\\ 0\\.018595031927504755\ \(0\)\
